Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

3,4-dimethyl-2,5-hexanedione

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
The effects of systemically introduced neurotoxic solvents 2,5-hexanedione (2,5-HD) and 3,4-dimethyl-2,5-hexanedione (DMHD) on… Expand
  • table I
  • figure 1
  • table II
Is this relevant?
1987
1987
Charles River CD rats (200 g) were divided into three groups receiving either 1% 2,5-hexanedione (2,5-HD) or 0.035% 3,4-dimethyl… Expand
Is this relevant?
1987
1987
The toxic syndrome resulting from in vivo exposure to n-hexane or n-hexane derivatives may, in part, be a manifestation of… Expand
Is this relevant?
1986
1986
The chronic exposure to gamma-diketones results in the formation of giant neurofilament (NF)-containing axonal enlargements… Expand
Is this relevant?
1985
1985
The neurofibrillary changes produced by IDPN are the consequence of the ability of the agent to impair the slow axonal transport… Expand
Is this relevant?
1984
1984
Accumulations of neurofilaments are observed in a variety of neurological disorders, and their pathogenesis is a fundamental… Expand
Is this relevant?
1984
1984
We have postulated that the toxic neuropathies associated with neurofilament-filled axonal swellings have a common pathogenesis… Expand
Is this relevant?
1983
1983
The neurotoxicity of the gamma-diketone 3,4-dimethyl-2,5-hexanedione(DMHD) was studied to determine the distribution of the… Expand
Is this relevant?
1983
1983
The neurotoxicity of the gamma-diketone, 3,4-dimethyl-2,5-hexanedione, was studied in rats and compared to the known… Expand
Is this relevant?
1983
1983
3,4-Dimethyl-2,5-hexanedione and 2,5-hexanedione were reacted with model amines to yield N-substituted 2,3,4,5… Expand
Is this relevant?